PERCEPTIVE ADVISORS LLC

Q2 2026 13F-HR Holdings

Location
New York, NY
Holdings as of
6/30/2026
Date filed
8/14/2026
Form type
13F-HR
Num holdings
109
Total value ($000)
$6,661,817
Net value change ($000)
+1,544,242 (30.2%)
New positions
23
Sold out positions
13
Turnover %
25.5%
Sector allocation + QoQ delta (equities-only)

Snapshot: Change Analysis

Compared to Q1 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
Ascendis Pharma AS 310,388 NEW
KARDIGAN INC 195,586 NEW
SYRE 192,659 101.0%
RLAY 166,903 172.0%
TVTX 90,109 73.2%
TNGX 88,658 524.4%
AVALYN PHARMACEUTICALS INC 88,071 NEW
RYTM 80,707 39.1%
RVMD 73,660 292.9%
BIIB 59,670 NEW
Top Reduces (Value $000, Stocks/ETFs)
ASND -350,282 -100.0%
CNTA -208,884 -100.0%
ENGN -39,685 -100.0%
DAWN -37,644 -100.0%
DRUG -27,549 -100.0%
NAUT -27,110 -55.5%
ABVX -26,760 -73.1%
DYN -24,918 -29.4%
BLTE -24,232 -100.0%
CELC -22,448 -6.3%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 221,310 (3.3% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type